Overcoming Challenges in Infectious Diseases
Discover the latest medical research on the prevention, management and treatment of infectious diseases.
LATEST TOPICS
-
Pathogen-specific strategies may improve prevention efforts of CLABSIs7 May, 2020Scientists from the National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention analysed central-line–associated bloodstream infection... -
Status of Levofloxacin in the perspective of HAP/VAP Guidelines17 April, 2020Professor Shi Yi Professor, Chief Physician, Doctoral Supervisor, Postdoctoral Supervisor Fellow of the American College of Chest Physicians Standing Committee Member of Respiratory... -
Managing pneumonia with artificial intelligence (AI)8 April, 2020As artificial intelligence (AI) becomes increasingly important in the global healthcare system, more scientists are using AI to improve public health efforts in the fight against infectious... -
First flu strain encountered sets the course for subsequent immune response17 March, 2020Scientists from the University of California, Los Angeles (UCLA) and the University of Arizona have found that the ability of an individual to fight flu is influenced by the strain first... -
Infectious diseases (ID) consultation increases survival by fourfold5 March, 2020Yet another study demonstrated the importance of infectious diseases (ID) consultation in improving the survival rate of a patient with septicaemia.1 This time, lack of ID consultation was... -
Is diabetes a risk factor for herpes zoster?20 February, 2020In line with the results from a previous meta-analysis that evaluated several studies on herpes zoster (HZ),1 the findings from a literature review by a group of researchers in France demonstrate... -
Levofloxacin reduces mortality rate in myeloma4 February, 2020A randomised placebo-controlled trial that aimed to tackle early morbidity and mortality in myeloma (TEAMM) revealed that prophylactic levofloxacin reduces the risk of infection and death in... -
Clinical practice of community-acquired pneumonia (CAP) in emergency department29 January, 2020Prof. Zhu Hua Dong Director Emergency Department of Peking Union Medical College Hospital Vice Chairman Office Director Deputy Chairman of Emergency Medical Education Expert... -
Application of quinolones in the emergency department20 January, 2020Professor Zhao Xiaodong Chief physician and Department Director Emergency Department of The First Affiliated Hospital of PLA General Hospital of China (Hospital 304) Q1: What kind...
-
Combination Therapy of Medications from the Perspective of PK / PD9 January, 2020Professor Zhang Jing Chief Pharmacist Institute of Antibiotics, Huashan Hospital, Fudan University Director Key Laboratory of Clinical Pharmacology of Antibiotics, National Health...
CONTENT LIBRARY
CONTENT LIBRARY
INTERVIEWS
-
Status of Levofloxacin in the perspective of HAP/VAP Guidelines -
Clinical practice of community-acquired pneumonia (CAP) in emergency department -
Application of quinolones in the emergency department -
Combination Therapy of Medications from the Perspective of PK / PD -
Antibiotic resistance and the role of high-dose, short-course levofloxacin in the treatment of pneumonia -
Sitafloxacin roles in the treatment of bacterial infections -
Interview on diagnosis and treatment of non-tuberculous mycobacterium infection -
High-dose, short-course levofloxacin versus conventional regimen for acute bacterial infection -
Recent update in the management of chronic obstructive pulmonary disease – an Asian perspective -
Levofloxacin: High-dose, short-course for bacterial infection